RT @BiotechObserver: @BayAreaBiotechI The bar is high. https://t.co/96piZkBNus https://t.co/jfPTdmdCbj https://t.co/YriZ5c5E43 https://t.…
@BayAreaBiotechI The bar is high. https://t.co/96piZkBNus https://t.co/jfPTdmdCbj https://t.co/YriZ5c5E43 https://t.co/fFLSXiJpFd $REGN $PIRS
Dupilimab - for EoE, asthma, polyps and eczema. Trials underway. @regeneron @RegeneronPharma @REGNCorpComm https://t.co/1tn8iFZXGW
"Dupilumab for severe asthma. How does it work? Is it any good? https://t.co/IjpwMOfA2c Open access https://t.co/0eFBItqqhJ"
Dupilumab for severe asthma. How does it work? Is it any good? https://t.co/XGWRirrMSi Open access https://t.co/Um299YY9cu
RT @FarmaCHUAC: 🔎📚 Revisión #Dupilumab en #asma moderada-grave https://t.co/395BJjlYeK
RT @FarmaCHUAC: 🔎📚 Revisión #Dupilumab en #asma moderada-grave https://t.co/395BJjlYeK
🔎📚 Revisión #Dupilumab en #asma moderada-grave https://t.co/395BJjlYeK
Dupilumab in the management of moderate-to-severe asthma: the data so far. https://t.co/lsRoouisHY